- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05909982
Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-1b) (PROTECT)
June 9, 2023 updated by: Ji Xunming,MD,PhD, Capital Medical University
Effect of Ischemic Post-conditioning on Infarct Volume in Patients With Acute Ischemic Stroke After Mechanical Thrombectomy
Ischemic post-conditioning is a neuroprotective strategy attenuating reperfusion injury in animal stroke models.
The investigators have conducted a 3 + 3 dose-escalation trial to demonstrate the safety and tolerability of ischemic post-conditioning incrementally for a longer duration of up to 5 min × 4 cycles in stroke patients undergoing mechanical thrombectomy.
This study aims to assess the infarct volume after ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xunming Ji, MD
- Phone Number: +86-10-83198952
- Email: jixm@ccmu.edu.cn
Study Contact Backup
- Name: Wenbo Zhao, M.D.
- Phone Number: 861083199086
- Email: zhaowb@xwh.ccmu.edu.cn
Study Locations
-
-
-
Tianjin, China, 300350
- Recruiting
- Tianjin Huanhu Hospital
-
Contact:
- Ming Wei, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥ 18 years;
- Acute ischemic stroke within 24 hours from stroke onset (or from time last known well) to groin puncture;
- Previous mRS ≤ 2;
- Baseline NIHSS ≥ 6;
- Baseline ASPECTS ≥ 6;
- With an occlusion of unilateral middle cerebral artery M1 segment/distal intracranial carotid artery;
- Successful recanalization (mTICI ≥ 2b) after thrombectomy confirmed by DSA;
- Written informed consent provided by the patients or their legal relatives.
Exclusion Criteria:
- Confirmed or clinically suspected cerebral vasculitis/fibromuscular dysplasia;
- Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning;
- Stenting in the middle cerebral artery M1 segment/distal intracranial carotid artery during thrombectomy;
- > 2 times balloon dilations as rescue therapy due to angioplasty during thrombectomy;
- Moderate/severe residual stenosis (≥ 50%) in the offending artery after thrombectomy;
- Patients with contraindications to MRI;
- Other conditions that the investigator considered inappropriate for inclusion.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ischemic post-conditioning group
Mechanical thrombectomy combined with ischemic post-conditioning
|
Ischemic post-conditioning will be applied after successful recanalization of the culprit artery by thrombectomy.
Ischemic post-conditioning consists of briefly repeated four cycles × 2 minutes of occlusion and reperfusion (equal duration) of the initially occluded artery using a balloon.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infarct volume
Time Frame: 72 hours after procedure
|
Infarct volume at 72 hours after procedure
|
72 hours after procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The progression of infarct volume
Time Frame: Baseline and 72 hours after procedure
|
Difference of infarct volume between baseline and 72 hours after procedure
|
Baseline and 72 hours after procedure
|
National Institute of Health Stroke Scale (NIHSS) score
Time Frame: 24 hours after procedure
|
NIHSS score at 24 hours after procedure; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
|
24 hours after procedure
|
The proportion of early neurological improvement
Time Frame: 24 hours after procedure
|
NIHSS 0-2 or ≥8 lower than baseline NIHSS score at 24 hours after procedure; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
|
24 hours after procedure
|
NIHSS score at 7 days after procedure/discharge
Time Frame: 7 days after procedure/discharge
|
NIHSS score at 7 days after procedure/discharge; the NIHSS ranges from 0 to 42, with higher scores indicating more severe neurologic deficits
|
7 days after procedure/discharge
|
Recanalization rate
Time Frame: 24 hours after procedure
|
Recanalization rate at 24 hours after procedure (mTICI ≥2b)
|
24 hours after procedure
|
The proportion of functional independence at 90 days
Time Frame: 90 days after procedure
|
The modified Rankin Scale (mRS) score of 0-2 at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
|
90 days after procedure
|
The proportion of favorable outcome at 90 days
Time Frame: 90 days after procedure
|
The mRS score of 0-3 at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
|
90 days after procedure
|
The distribution of the mRS score at 90 days
Time Frame: 90 days after procedure
|
The distribution of the mRS score at 90 days after procedure; the mRS is an ordinal disability score of 7 categories (0=no symptoms to 5=severe disability, and 6=death)
|
90 days after procedure
|
Hemodynamic assessment
Time Frame: Within 24 hours after procedure
|
Hemodynamic assessment within 24 hours after procedure
|
Within 24 hours after procedure
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety outcome (mortality at 90 days)
Time Frame: 90 days after procedure
|
90-day mortality
|
90 days after procedure
|
Procedure-related complications
Time Frame: During the procedure
|
Vascular perforation/rupture, vessel dissection, severe vasospasm, rupture of the balloon used for post-conditioning
|
During the procedure
|
Safety outcome (the proportion of symptomatic intracranial hemorrhage within 24 hours)
Time Frame: Within 24 hours after procedure
|
The proportion of symptomatic intracranial hemorrhage within 24 hours after procedure
|
Within 24 hours after procedure
|
Safety outcome (the proportion of intracranial hemorrhage within 24 hours)
Time Frame: Within 24 hours after procedure
|
The proportion of intracranial hemorrhage within 24 hours after procedure
|
Within 24 hours after procedure
|
Safety outcome (the proportion of malignant brain edema within 24 hours)
Time Frame: Within 24 hours after procedure
|
The proportion of malignant brain edema within 24 hours after procedure
|
Within 24 hours after procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Estimated)
December 31, 2023
Study Completion (Estimated)
March 31, 2024
Study Registration Dates
First Submitted
June 9, 2023
First Submitted That Met QC Criteria
June 9, 2023
First Posted (Estimated)
June 19, 2023
Study Record Updates
Last Update Posted (Estimated)
June 19, 2023
Last Update Submitted That Met QC Criteria
June 9, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Necrosis
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Postoperative Complications
- Brain Ischemia
- Infarction
- Brain Infarction
- Stroke
- Ischemic Stroke
- Ischemia
- Cerebral Infarction
- Reperfusion Injury
Other Study ID Numbers
- PROTECT-1b
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reperfusion Injury
-
University of ChileFondo Nacional de Desarrollo Científico y Tecnológico, ChileCompletedReperfusion Injury | Acute Myocardial Infarction | Ischemia-reperfusion Injury | Reperfusion Injury, Myocardial | Reperfusion ArrhythmiasChile
-
University of AarhusCompletedReperfusion Injuries, Myocardial
-
University of AarhusErasmus Medical Center; Fonden til Lægevidenskabens FremmeCompletedIschemia Reperfusion Injury | Ischaemia Reperfusion InjuryDenmark
-
Indonesia UniversityEnrolling by invitationReperfusion Injury, MyocardialIndonesia
-
Chinese PLA General HospitalUnknown
-
West Kazakhstan Medical UniversityRecruitingKidney Transplantation | Ischemic Reperfusion Injury | ReperfusionKazakhstan
-
Cukurova UniversityCompleted
-
Chinese PLA General HospitalUnknownReperfusion Injury, Myocardial
-
Shahid Beheshti University of Medical SciencesPooyesh DarouCompletedMyocardial Ischemic Reperfusion InjuryIran, Islamic Republic of
-
Samsung Medical CenterCompletedIschemia/Reperfusion Injury of Liver Graft | Ischemia/Reperfusion Injury of Kidney | Remote Ischemic PostconditioningKorea, Republic of
Clinical Trials on Mechanical thrombectomy combined with ischemic post-conditioning
-
Capital Medical UniversityNot yet recruitingAcute Ischemic StrokeChina
-
Tianjin Huanhu HospitalRecruitingAcute Ischemic Stroke | Large Vessel Occlusion | Endovascular ThrombectomyChina
-
Capital Medical UniversityCompletedAcute Ischemic StrokeChina
-
Chonnam National University HospitalTerminatedOut-Of-Hospital Cardiac ArrestKorea, Republic of
-
Beth Israel Deaconess Medical CenterUnknown
-
ThrombX MedicalNot yet recruitingIschemic Stroke
-
José García de la AsunciónCompleted
-
Hospices Civils de LyonActive, not recruitingMyocardial Infarction, AcuteBelgium, France
-
Hospices Civils de LyonCompleted
-
Hospices Civils de LyonUnknown